Why Madison Square Garden Sports (MSGS) is Back on Investor Radars

Madison Square Garden Sports (MSGS) stock has been drawing fresh attention after posting annual revenue of US$1,071.0 million and net income of US$16.6 million, prompting investors to reassess how this professional sports company is currently valued.

At a share price of US$332.52, Madison Square Garden Sports has seen a 19.06% 90 day share price return and a 74.18% 1 year total shareholder return, suggesting momentum has been building despite some recent short term pullback.

If this kind of momentum has your attention, it can be worth widening the search to other opportunities using the 18 top founder-led companies

With a recent share price of US$332.52, a loss of US$16.6 million and a price target implying some upside, investors are asking a key question: is MSGS still undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 4.6% Undervalued

At a last close of $332.52 versus an implied fair value of $348.60, the most followed narrative sees some upside still on the table, driven by media economics and franchise appeal rather than short term trading swings.

The upcoming ramp-up in high-value national media rights fees for the NBA (beginning in fiscal '26) will offset the recent step-down in local media rights, positioning MSG Sports for an overall increase in recurring media revenue and supporting both revenue growth and higher net margins over the next several years.

Want to see what really underpins that fair value gap? The narrative leans on steady revenues, rising margins, and a future earnings multiple that stands out from peers.

Result: Fair Value of $348.60 (UNDERVALUED)

However, there are still clear pressure points, including reduced local media rights fees and heavy reliance on just the Knicks and Rangers to support the entire story.

Another Angle on Valuation

The fair value narrative suggests about 4.6% upside to $348.60, but the market price tells a different story when you look at P/S. MSGS trades at 7.5x sales versus 3.2x for peers and a fair ratio of 1.1x, which points to a rich setup rather than a clear discount. So which signal matters more for you?

Next Steps

Curious whether the balance of optimism and concern here matches your own view? Take a closer look at the data, form your own judgment, and weigh the 1 key reward and 2 important warning signs.

Looking for more investment ideas?

If MSGS has sharpened your focus, do not stop here. Broaden your watchlist with other clear, data backed ideas before the next move passes you by.

• Target resilience by scanning companies with stronger cash buffers and manageable debt using the solid balance sheet and fundamentals stocks screener (44 results).
• Hunt for quality at a reasonable price by checking stocks that screen as potentially mispriced on fundamentals through the 51 high quality undervalued stocks.
• Prioritise consistency in your income plan by reviewing companies with higher yields and sturdier payout profiles using the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.